![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Two-Week Course of Sleep Aid Increases Adherence in OSA Patients
Two-Week Course of Sleep Aid Increases Adherence in OSA Patients
May 18, 2009
New research suggests that patients newly diagnosed with obstructive sleep apnea (OSA) who use a short-course of the sleep aid, eszopiclone, when beginning continuous positive airway pressure therapy, are more adherent with therapy in six months.
EurekAlert!
EurekAlert!
Upcoming Events
-
21Oct